I now have comprehensive textbook content. Here is a detailed breakdown of the Ann Arbor staging system for Non-Hodgkin Lymphoma (NHL) with clinical examples for each stage.
Ann Arbor Staging of Non-Hodgkin Lymphoma (NHL)
Originally developed in 1971 for Hodgkin lymphoma, the Ann Arbor system was adapted for NHL. It classifies disease based on number of tumor sites (nodal and extranodal), location relative to the diaphragm, and presence/absence of systemic (B) symptoms.
Stage Definitions & Examples
Stage I
Single lymph node region (I) or a single extranodal site (IE)
| Subtype | Example |
|---|
| I | Isolated right cervical (neck) lymphadenopathy from follicular lymphoma, with no other nodal or organ involvement |
| IE | A solitary extranodal mass — e.g., primary gastric MALT lymphoma confined to the stomach wall, without any nodal involvement |
Stage II
Two or more lymph node regions on the same side of the diaphragm (II), or with contiguous extranodal involvement (IIE)
| Subtype | Example |
|---|
| II | Enlarged cervical and ipsilateral axillary lymph nodes (both above the diaphragm) in a patient with DLBCL — no organ involvement |
| IIE | Mediastinal and bilateral hilar lymphadenopathy plus contiguous involvement of the adjacent lung parenchyma (all above the diaphragm) |
Stage III
Lymph node regions on both sides of the diaphragm (III), possibly with spleen (IIIS), contiguous extranodal site (IIIE), or both (IIIES)
| Subtype | Example |
|---|
| III | Cervical lymphadenopathy (above diaphragm) + para-aortic lymphadenopathy (below diaphragm) in follicular lymphoma |
| IIIS | Same as above, but with splenic involvement detected on PET/CT |
| IIIE | Bilateral cervical + retroperitoneal nodes + contiguous involvement of one kidney |
| IIIES | Mediastinal + mesenteric nodes + splenic involvement + contiguous involvement of the small bowel |
Stage IV
Diffuse or disseminated involvement of one or more extranodal organs, with or without lymph node involvement
| Example |
|---|
| DLBCL with widespread lymphadenopathy + bone marrow infiltration (the classic Stage IV indicator) |
| NHL with liver involvement (hepatic parenchymal deposits) + multiple nodal sites |
| Burkitt lymphoma involving multiple organs — kidneys, liver, and CNS — alongside nodal disease |
| Follicular lymphoma with peripheral blood lymphocytosis (leukemic phase) + nodal disease |
A and B Suffixes (Apply to All Stages)
| Suffix | Meaning | Example |
|---|
| A | No systemic symptoms | Stage IIA = bilateral cervical + axillary nodes, no fevers/sweats/weight loss |
| B | Presence of: unexplained fever >38°C, drenching night sweats, OR weight loss >10% body weight over 6 months | Stage IIIB = bilateral nodes on both sides of diaphragm + night sweats |
Additional Notation
- E = Extranodal contiguous extension (e.g., IIE, IIIE)
- S = Splenic involvement (e.g., IIIS)
- X = Bulky disease (mass >10 cm or mediastinal mass >1/3 chest diameter)
Key Caveat for NHL
The Ann Arbor system is less clinically useful for NHL than for Hodgkin lymphoma because NHL does not spread in an orderly stepwise nodal fashion. The majority of NHL patients already have advanced-stage (III–IV) disease at diagnosis. As a result, histology and the International Prognostic Index (IPI) — incorporating age, LDH, performance status, stage, and extranodal sites — are more important determinants of prognosis and therapy than stage alone.
Sources: Harrison's Principles of Internal Medicine 22E, p. 904 | Robbins & Kumar Basic Pathology, p. 421 | Goldman-Cecil Medicine